Skip to main content
. 2016 Jan 27;103(3):910–918. doi: 10.3945/ajcn.115.120055

TABLE 2.

Changes in HAZs, WAZs, and WHZs over 18 mo of follow-up across the 4 treatment groups1

Zn+MVs (n = 602) Zinc only (n = 596) Multivitamins only (n = 598) Placebo (n = 604)
Change in HAZ −0.79 ± 0.05 −0.93 ± 0.05 −0.88 ± 0.05 −0.93 ± 0.05
 P 0.058 0.956 0.478 Referent
Change in WAZ −0.36 ± 0.04 −0.61 ± 0.04 −0.52 ± 0.04 −0.50 ± 0.04
 P 0.020 0.063 0.792 Referent
Change in WHZ −0.31 ± 0.07 −0.57 ± 0.07 −0.42 ± 0.07 −0.35 ± 0.07
 P 0.655 0.021 0.473 Referent
1

All values are mean ± SEs. The analysis was derived from a mixed-effects model with restricted cubic splines. P values are for comparisons of the mean change in z score compared with the mean change in z score in the placebo group. HAZ, height-for-age z score; WAZ, weight-for-age z score; WHZ, weight-for-height z score; Zn+MV, zinc and multivitamin.